
James McCloskey
Physician · Regional Cancer Care Associates LLC
Credentials: · · · · · ·
History
- Present
Regional Cancer Care Associates LLC
- 2011–2014
Hematology and Medical Oncology


Research
Blood · 2021 · 195 citations
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Journal of Clinical Oncology · 2022 · 173 citations
Blood · 2021 · 172 citations

9 papers

8 papers

8 papers

6 papers

6 papers

6 papers

5 papers

5 papers
Clinical trials
- 2019–2023
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
Principal investigator · Terminated · Phase 1
Hackensack Meridian Health
- 2024–2027
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Site PI · Recruiting · Phase 1
SystImmune Inc.
- 2023–2026
Phase IB/II of CPX-351 for Relapse Prevention in AML
Site PI · Recruiting · Phase 1, Phase 2
Georgetown University


